These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30496814)

  • 1. The antimetastatic effect and underlying mechanisms of thioredoxin reductase inhibitor ethaselen.
    Zheng X; Chen Y; Bai M; Liu Y; Xu B; Sun R; Zeng H
    Free Radic Biol Med; 2019 Feb; 131():7-17. PubMed ID: 30496814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent.
    Wang L; Yang Z; Fu J; Yin H; Xiong K; Tan Q; Jin H; Li J; Wang T; Tang W; Yin J; Cai G; Liu M; Kehr S; Becker K; Zeng H
    Free Radic Biol Med; 2012 Mar; 52(5):898-908. PubMed ID: 22210352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of plasma thioredoxin reductase activity to growth of H22 hepatocellular carcinoma xenografts in Kunming mice].
    Tan Q; Ren XY; Li J; Wang F; Deng SJ; Zeng HH
    Ai Zheng; 2009 May; 28(5):472-7. PubMed ID: 19624873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mechanism of ethaselen in poorly differentiated colorectal RKO cell growth inhibition: Simultaneous regulation of TrxR transcription, expression and enzyme activity.
    Yin H; Li J; Xiong K; Wang L; Wang T; Tan Q; Fu J; Ren X; Zeng H
    Differentiation; 2011 Jan; 81(1):49-56. PubMed ID: 20864247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibitory effect of a novel organoselenium compound BBSKE on the tongue cancer Tca8113 in vitro and in vivo.
    Xing F; Li S; Ge X; Wang C; Zeng H; Li D; Dong L
    Oral Oncol; 2008 Oct; 44(10):963-9. PubMed ID: 18282784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thioredoxin reductase inhibitor ethaselen increases the drug sensitivity of the colon cancer cell line LoVo towards cisplatin via regulation of G1 phase and reversal of G2/M phase arrest.
    Fu JN; Li J; Tan Q; Yin HW; Xiong K; Wang TY; Ren XY; Zeng HH
    Invest New Drugs; 2011 Aug; 29(4):627-36. PubMed ID: 20195699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel organoselenium compound induces cell cycle arrest and apoptosis in prostate cancer cell lines.
    Shi C; Yu L; Yang F; Yan J; Zeng H
    Biochem Biophys Res Commun; 2003 Sep; 309(3):578-83. PubMed ID: 12963029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Induction of apoptosis in prostate cancer cell line PC-3 by BBSKE, a novel organoselenium compound, and its effect in vivo].
    Shi CJ; Zeng HH; Li HW; Yang FG; Wu XQ; Yu LZ
    Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(22):1984-8. PubMed ID: 14703435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thioredoxin 1 mediates TGF-β-induced epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.
    Jiang Y; Feng X; Zheng L; Li SL; Ge XY; Zhang JG
    Oncotarget; 2015 Sep; 6(28):25506-19. PubMed ID: 26325518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect of ethaselen and selenite treatment against A549 human non-small cell lung cancer cells.
    Xu W; Ma WW; Zeng HH
    Asian Pac J Cancer Prev; 2014; 15(17):7129-35. PubMed ID: 25227802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of apoptosis induced by a novel thioredoxin reductase inhibitor in A549 cells: possible involvement of nuclear factor-kappaB-dependent pathway.
    Lan L; Zhao F; Wang Y; Zeng H
    Eur J Pharmacol; 2007 Jan; 555(2-3):83-92. PubMed ID: 17116300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selenium-containing thioredoxin reductase inhibitor ethaselen sensitizes non-small cell lung cancer to radiotherapy.
    Wang L; Fu JN; Wang JY; Jin CJ; Ren XY; Tan Q; Li J; Yin HW; Xiong K; Wang TY; Liu XM; Zeng HH
    Anticancer Drugs; 2011 Sep; 22(8):732-40. PubMed ID: 21562407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel thioredoxin reductase inhibitor inhibits cell growth and induces apoptosis in HL-60 and K562 cells.
    Peng ZF; Lan LX; Zhao F; Li J; Tan Q; Yin HW; Zeng HH
    J Zhejiang Univ Sci B; 2008 Jan; 9(1):16-21. PubMed ID: 18196608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of tri-block copolymer micelles loading novel organoselenium anticancer drug BBSKE and study of tissue distribution of copolymer micelles by imaging in vivo method.
    Liu M; Fu J; Li J; Wang L; Tan Q; Ren X; Peng Z; Zeng H
    Int J Pharm; 2010 May; 391(1-2):292-304. PubMed ID: 20211232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A thioredoxin reductase inhibitor induces growth inhibition and apoptosis in five cultured human carcinoma cell lines.
    Zhao F; Yan J; Deng S; Lan L; He F; Kuang B; Zeng H
    Cancer Lett; 2006 May; 236(1):46-53. PubMed ID: 15982805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7.
    Fang XJ; Jiang H; Zhao XP; Jiang WM
    BMC Cancer; 2011 Jul; 11():290. PubMed ID: 21749678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
    Ziegler E; Hansen MT; Haase M; Emons G; Gründker C
    Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion.
    Zhang T; Li J; Dong Y; Zhai D; Lai L; Dai F; Deng H; Chen Y; Liu M; Yi Z
    Breast Cancer Res Treat; 2012 Sep; 135(2):445-58. PubMed ID: 22842972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.
    Khan MA; Tania M; Wei C; Mei Z; Fu S; Cheng J; Xu J; Fu J
    Oncotarget; 2015 Aug; 6(23):19580-91. PubMed ID: 26023736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.